Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $38.2900 (4.7%) ($38.2900 - $38.3100) on Wed. Mar. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.96% (three month average) | RSI | 40 | Latest Price | $38.2900(4.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 3.1% a day on average for past five trading days. | Weekly Trend | HALO declines -7.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(44%) IFRA(43%) XBI(43%) IWO(42%) IWM(40%) | Factors Impacting HALO price | HALO will decline at least -1.48% in a week (0% probabilities). VXX(-19%) VIXM(-11%) UUP(-9%) GLD(-9%) IGOV(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.48% (StdDev 2.96%) | Hourly BBV | 1.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $38.93 | 5 Day Moving Average | $35.79(6.99%) | 10 Day Moving Average | $35.11(9.06%) | 20 Day Moving Average | $38.93(-1.64%) | To recent high | -32.8% | To recent low | 16.6% | Market Cap | $5.233b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |